الصفحة الرئيسية>>Signaling Pathways>> PROTAC>>Tr-PEG2-OH

Tr-PEG2-OH

رقم الكتالوجGC66952

Tr-PEG2-OH عبارة عن رابط PROTAC قائم على PEG يمكن استخدامه في تركيب PROTACs. Tr-PEG2-OH هو أيضًا رابط PEG ADC مكون من وحدتين غير قابل للكسر يستخدم في تخليق اتحادات الأجسام المضادة والأدوية (ADCs).

Products are for research use only. Not for human use. We do not sell to patients.

Tr-PEG2-OH التركيب الكيميائي

Cas No.: 105589-77-3

الحجم السعر المخزون الكميّة
1g
951٫00
متوفر

Tel:(909) 407-4943 Email: sales@glpbio.com

مراجعات العميل

بناء على آراء العملاء.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Tr-PEG2-OH is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs[1]. Tr-PEG2-OH is also a non-cleavable 2 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs)[2].

PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins[1]. ADCs are comprised of an antibody to which is attached an ADC cytotoxin through an ADC linker[2].

[1]. An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562.
[2]. Beck A, et al. Strategies and challenges for the next generation of antibody-drug conjugates. Nat Rev Drug Discov. 2017 May;16(5):315-337.

مراجعات

Review for Tr-PEG2-OH

Average Rating: 5 ★★★★★ (Based on Reviews and 30 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Tr-PEG2-OH

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.